Steve M. Sabus

Insider Reports History

Entity
Individual
Location
10628 Science Center Drive, Suite 200, San Diego, California
Signature
/s/ Michael A. Metzger, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Steve M. Sabus:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Syndax Pharmaceuticals Inc Chief Commercial Officer Stock Options (Right to buy) 220,000 $5.69 M $25.84 Dec 5, 2022 Direct
Turning Point Therapeutics, Inc. SVP & Chief Commercial Officer Common Stock 0 $76.00 Aug 17, 2022 Direct
Turning Point Therapeutics, Inc. SVP & Chief Commercial Officer Stock Option (right to buy) 0 Aug 17, 2022 Direct

Insider Reports Filed by Steve M. Sabus

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SNDX Syndax Pharmaceuticals Inc Dec 5, 2022 1 5,596,800 4 Dec 5, 2022 Chief Commercial Officer
SNDX Syndax Pharmaceuticals Inc Dec 5, 2022 0 0 3 Dec 5, 2022 Chief Commercial Officer
TPTX Turning Point Therapeutics, Inc. Aug 17, 2022 2 -2,786,692 4 Aug 17, 2022 SVP & Chief Commercial Officer
TPTX Turning Point Therapeutics, Inc. May 31, 2022 2 0 4 Jun 1, 2022 SVP & Chief Commercial Officer
TPTX Turning Point Therapeutics, Inc. May 31, 2022 0 0 3 Jun 1, 2022 SVP & Chief Commercial Officer